From: Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment
Molecular landscape | Highlight | Ref |
---|---|---|
Kirsten rat sarcoma viral oncogene (KRAS) | KRAS controls the storage and use of lipid droplets through HSL regulation that shows downregulation in PC Suppression of the KRAS/HSL axis impairs lipid metabolism and storage and suppresses invasion and metastasis | [52] |
Branched-chain amino acid (BCAA) | BCAA uptake in the PC cells is mediated by solute carrier transporters The downregulation of Branched-chain amino-acid transaminase 2 (BCAT2) impairs cancer progression | [53] |
Sterol regulatory element binding protein (SREBP1) | Upregulation of SREBP1 mediates poor survival and prognosis SREB1 increases ACC, FASN, Stearoyl-CoA desaturase–1 (SCD1), and lipogenesis Downregulation of SREBP1 induces apoptosis | [54] |
Hydroxysteroid dehydrogenase-like protein 2 (HSDL2) | Overexpression of HSDL2 in PC mediating poor survival HSDL2 downregulation impairs lipid metabolism and proliferation | [55] |
Sterol Regulatory Element-Binding Transcription Factor 1 (SREBF1) | Yarrow supercritical extract reduces SREBF1 expression to suppress lipid metabolism through the downregulation of Stearoyl-CoA desaturase (SCD) and FASN | [56] |
KRASG12D | KRASG12D increases SLC25A1 expression to enhance lipid metabolism in cancer progression | [57] |
G-protein (GNAS) | GNAS mutation increases protein kinase A (PKA) -induced salt-inducible kinases (Sik1) inhibition and promotes lipid metabolism | [58] |
Adipocytes | Adipocytes enhance lipid droplets in promoting cancer invasion | [59] |
phospholipase A2 group IIA (PLA2G2A) phospholipase | PLA2G2A enhances FASN and energy metabolism during K-ras mutation | [60] |
FASN | FASN suppression accelerates apoptosis | [61] |
FAs | The FAs stimulate stromal reprogramming to enhance inflammation and fibrosis for fuelling PC | [62] |
Heptadecanoic acid | Heptadecanoic acid as an FA stimulates apoptosis and promotes gemcitabine sensitivity | [63] |